Bernhard Ortel to Prostatic Neoplasms
This is a "connection" page, showing publications Bernhard Ortel has written about Prostatic Neoplasms.
Connection Strength
0.285
-
Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer. 2002 Nov 18; 87(11):1321-7.
Score: 0.099
-
Laser-induced hyperthermia in rat prostate cancer: role of site of tumor implantation. Urology. 2000 Jul; 56(1):167-72.
Score: 0.084
-
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer. 2006 Aug 21; 95(4):485-95.
Score: 0.032
-
Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats. Prostate. 2003 Feb 15; 54(3):206-11.
Score: 0.025
-
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene. 2002 Mar 27; 21(13):2089-96.
Score: 0.024
-
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model. Prostate. 2000 May 01; 43(2):77-82.
Score: 0.021